# 2025-21183: Company Named After Tax Haven Wants Drug Manufacturing License

2025-21183, Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-11-26, effective Registered bulk manufacturers and applicants may submit comments or objections, or request a hearing, on or before January 26, 2026. (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-21183
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-21183
- Title: Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 54380
- Published: 2025-11-26
- Effective: Registered bulk manufacturers and applicants may submit comments or objections, or request a hearing, on or before January 26, 2026.
- Comments close: 2026-01-26
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Company Named After Tax Haven Wants Drug Manufacturing License

## Summary

Cayman Chemical Company wants to become an official big-time maker of certain controlled substances, mostly powerful chemicals in Schedule I. This affects other manufacturers and the public, who can share their thoughts or ask for a hearing by January 26, 2026. No direct money changes yet, but this move could impact how these substances are made and regulated.

## Abstract

Cayman Chemical Company has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-21183 on federalregister.gov](https://www.federalregister.gov/documents/2025/11/26/2025-21183/bulk-manufacturer-of-controlled-substances-application-cayman-chemical-company)
- [2025-21183 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-11-26/pdf/2025-21183.pdf)

## Related
- [Previous: 2025-21182, Bulk Manufacturer of Controlled Substances Application: Groff NA Hemplex LLC](https://policyrisk.com/federal-register/2025-21182)
- [Next: 2025-21184, Bulk Manufacturer of Controlled Substances Application: Eli-Elsohly Laboratories](https://policyrisk.com/federal-register/2025-21184)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-21183 (as of 2026-06-08).
